Auris Nasus Larynx:成年人扁桃腺切除术分析

2017-09-27 AlexYang MedSci原创

扁桃腺切除术是外科手术中耳鼻喉科专家最为常用的手术之一,并且尽管是一个相对简单的手术,它能够产生相当大比例的并发症,比如术后出血。最近,有研究人员描述了该外科手术的适应症和最常见的并发症,分析了是否扁桃体支柱的外科手术缝合线对出血具有影响以及研究了住院数据和并发症控制的重要性。研究为回顾性的研究,包括了326名经历了扁桃腺切除的病人,时间为2006年到2014年,地点为研究人员所在的耳鼻喉部门。研

扁桃腺切除术是外科手术中耳鼻喉科专家最为常用的手术之一,并且尽管是一个相对简单的手术,它能够产生相当大比例的并发症,比如术后出血。最近,有研究人员描述了该外科手术的适应症和最常见的并发症,分析了是否扁桃体支柱的外科手术缝合线对出血具有影响以及研究了住院数据和并发症控制的重要性。

研究为回顾性的研究,包括了326名经历了扁桃腺切除的病人,时间为2006年到2014年,地点为研究人员所在的耳鼻喉部门。研究人员利用Excel和SPSS 21.0对获得的数据进行了统计学分析。研究发现,最为常见的适应症为慢性扁桃体炎,占比为74.85%(244),最为常见的并发症为出血,扁桃体切除术中占比为5.21%(17),其中需要再次手术的为13例。另外,在扁桃体支柱缝合线和无缝合线病人中,出血风险方面没有显著的差异。在外科手术适应症和口咽术后出血之间也没有检测到显著的差异。另外,所有进行手术的病人都进行了入院治疗,术后平均住院时间为2.17天,并且获得了快速和有效的直接并发症控制。最后,研究人员指出,出血是最常见和重要的并发症。然而,研究人员并没有在出血和扁桃体支柱缝合或者外科手术适应症之间发现显著的联系。目前,扁桃体手术还不能设置为门诊手术。

原始出处:

Galindo Torres BP, De Miguel García F, Whyte Orozco J. Tonsillectomy in adults: Analysis of indications and complications. Auris Nasus Larynx. 16 September 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1876949, encodeId=976c18e6949b6, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 30 14:04:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248290, encodeId=2d1e248290dc, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:48:06 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248289, encodeId=de41248289f0, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:47:53 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248285, encodeId=df20248285aa, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Sep 27 21:46:02 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1876949, encodeId=976c18e6949b6, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 30 14:04:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248290, encodeId=2d1e248290dc, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:48:06 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248289, encodeId=de41248289f0, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:47:53 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248285, encodeId=df20248285aa, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Sep 27 21:46:02 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 qingfengqishi5

    学习了.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1876949, encodeId=976c18e6949b6, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 30 14:04:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248290, encodeId=2d1e248290dc, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:48:06 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248289, encodeId=de41248289f0, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:47:53 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248285, encodeId=df20248285aa, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Sep 27 21:46:02 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 qingfengqishi5

    学习了.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1876949, encodeId=976c18e6949b6, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sat Sep 30 14:04:00 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248290, encodeId=2d1e248290dc, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:48:06 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248289, encodeId=de41248289f0, content=学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Sep 27 21:47:53 CST 2017, time=2017-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248285, encodeId=df20248285aa, content=学习了谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Wed Sep 27 21:46:02 CST 2017, time=2017-09-27, status=1, ipAttribution=)]
    2017-09-27 1e145228m78(暂无匿称)

    学习了谢谢作者分享!

    0

相关资讯

扁桃体干细胞或可用于肝脏损伤治疗

研究表明肝脏对身体来说具有非常重要的作用,比如它能清除身体毒素。缺少肝脏对人体来说是致命的,如果它受到损害,相对来说是很难治愈的。但是科学家们发表在ACS Applied Materials & Interfaces 杂志上的文章指出可以抽取扁桃体中的干细胞(这一部分是我们身体所不需要的)来修复受损肝脏器官,且全程无需动手术便可实施。 Byeongmoon Jeong 和他的同事们指

外媒称人体“多余”器官大有用处:阑尾可抵抗癌症

外媒称,过去人们认为,脾脏不太重要,而扁桃体和阑尾更是毫无用处——是返祖现象和退化器官。现代医学是如何看待这一问题的?

Cancer:腭扁桃体鳞状细胞癌单边和双边调强放射治疗比较

最近,有作者提出了这样的一个假设,即对患有单侧性的腭扁桃体癌和N0到N2b疾病分级且具有相似肿瘤结果的病人来说,单边调强放射治疗(IMRT)与双边IMRT相比会减少毒性。研究有154名病人在1997年到2013年接受了术后IMRT治疗。研究人眼前瞻性的收集了2005年到2013年的数据,并且回顾性的收集了2005年前的数据。对那些患有单侧性初级和N0到N2b颈部分级的病人,48名病人接受了单边IM

警惕:难缠的咽痛——扁桃体周围脓肿

临床工作中,遇到难缠逐渐加重的咽痛,切勿以为都是急性扁桃体炎,应警惕扁桃体周围脓肿的形成,早期发现,早期抽脓!

Int Arch Otorhinolaryngol:抽烟对慢性/复发性扁桃体炎和扁桃腺切除术后出血的影响

抽烟对口腔和咽黏膜有着许多的不良作用。结果可能是发展成为扁桃体感染和诱导扁桃腺切除术后出血(PTB)。最近,有研究人员就是否抽烟者患有更多的慢性/复发性扁桃体炎或者发展成为更多的PTB进行了研究。研究采用了一种回顾性的研究,包括了两个成年人组。组1为因慢性/复发性扁桃体炎而经历了扁桃腺切除术的抽烟者;组2为慢性/复发性扁桃体炎PTB需要控制抽烟量的病人群体。组1主要作为组2的群体参照。研究人员从医

说说肾病患者扁桃体那些事儿

扁桃体是人体免疫活性器官之一,它可产生淋巴细胞和抗体直接对抗入侵体内的细菌和病毒,就如同一个个卫士镇守在人体与外界接触的边防要塞。